Tests show patients who take Wegovy experience weight loss of approx. 15kg over 64 weeks Dubai: A pill version of the world’s most closely watched weight-loss drug is edging closer to global rollout, ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

One of Eli Lilly’s most promising new obesity drugs helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis. The drug giant’s LLY stock was ...

Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...

Compared with individuals who maintained their weight from diagnosis, a 5% to 10% weight loss or greater than 10% weight loss at 2 years following RCC diagnosis was associated with worse OS. Weight ...

Novo Nordisk said a weight-loss drug candidate helped patients lose weight and reduce blood-sugar levels in pill and injection forms during a mid-stage trial, lifting shares in the company. The Danish ...

Data helps predict which drug will help specific patients lose weight Researchers used AI to analyze effect on patients’ other medical conditions Drug benefit-risk scores need to be developed, tested ...

Some people don’t lose enough weight after bariatric surgery, but a new study shows that adding a daily shot of GLP-1 drug liraglutide can help patients shed extra pounds and may reduce the need for ...

Weight-loss drugs have been found to dramatically slash death rates in colon cancer patients, according to new research. Patients taking GLP-1 receptors - the class of drugs behind Ozempic, Wegovy and ...

I founded the Pacific Obesity Alliance with a vision to educate and engage healthcare professionals to provide every person affected by overweight or obesity with access to compassionate, ...